These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 30358904)
61. The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics. Brown EM Subcell Biochem; 2007; 45():139-67. PubMed ID: 18193637 [TBL] [Abstract][Full Text] [Related]
62. Clinical and laboratory features of calcium-sensing receptor disorders: a systematic review. Gunn IR; Gaffney D Ann Clin Biochem; 2004 Nov; 41(Pt 6):441-58. PubMed ID: 15588433 [TBL] [Abstract][Full Text] [Related]
63. Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism. Linglart A; Rothenbuhler A; Gueorgieva I; Lucchini P; Silve C; Bougnères P J Clin Endocrinol Metab; 2011 Nov; 96(11):3308-12. PubMed ID: 21865375 [TBL] [Abstract][Full Text] [Related]
64. A practical approach to hypocalcaemia in children. Shaw N Endocr Dev; 2009; 16():73-92. PubMed ID: 19494662 [TBL] [Abstract][Full Text] [Related]
68. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. Alimohammadi M; Björklund P; Hallgren A; Pöntynen N; Szinnai G; Shikama N; Keller MP; Ekwall O; Kinkel SA; Husebye ES; Gustafsson J; Rorsman F; Peltonen L; Betterle C; Perheentupa J; Akerström G; Westin G; Scott HS; Holländer GA; Kämpe O N Engl J Med; 2008 Mar; 358(10):1018-28. PubMed ID: 18322283 [TBL] [Abstract][Full Text] [Related]
69. A novel mutation in the calcium-sensing receptor responsible for autosomal dominant hypocalcemia in a family with two uncommon parathyroid hormone polymorphisms. Alvarez-Hernández D; Santamaría I; Rodríguez-García M; Iglesias P; Delgado-Lillo R; Cannata-Andía JB J Mol Endocrinol; 2003 Oct; 31(2):255-62. PubMed ID: 14519094 [TBL] [Abstract][Full Text] [Related]
70. Idiopathic hypoparathyroidism and autoimmunity. Burckhardt P Horm Res; 1982; 16(5):304-7. PubMed ID: 7173822 [TBL] [Abstract][Full Text] [Related]
71. Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism. Canaff L; Zhou X; Mosesova I; Cole DE; Hendy GN Hum Mutat; 2009 Jan; 30(1):85-92. PubMed ID: 18712808 [TBL] [Abstract][Full Text] [Related]
72. CASR gene activating mutations in two families with autosomal dominant hypocalcemia. Guarnieri V; Valentina D'Elia A; Baorda F; Pazienza V; Benegiamo G; Stanziale P; Copetti M; Battista C; Grimaldi F; Damante G; Pellegrini F; D'Agruma L; Zelante L; Carella M; Scillitani A Mol Genet Metab; 2012 Nov; 107(3):548-52. PubMed ID: 22789683 [TBL] [Abstract][Full Text] [Related]
73. A novel activating mutation (C129S) in the calcium-sensing receptor gene in a Japanese family with autosomal dominant hypocalcemia. Hirai H; Nakajima S; Miyauchi A; Nishimura K; Shimizu N; Shima M; Michigami T; Ozono K; Okada S J Hum Genet; 2001; 46(1):41-4. PubMed ID: 11289719 [TBL] [Abstract][Full Text] [Related]
74. Rapid increase in bone mineral density in a child with osteoporosis and autoimmune hypoparathyroidism treated with PTH 1-34. Koch CA Exp Clin Endocrinol Diabetes; 2001; 109(6):350-4. PubMed ID: 11571675 [TBL] [Abstract][Full Text] [Related]
75. Novel activating mutation of human calcium-sensing receptor in a family with autosomal dominant hypocalcaemia. Baran N; ter Braak M; Saffrich R; Woelfle J; Schmitz U Mol Cell Endocrinol; 2015 May; 407():18-25. PubMed ID: 25766501 [TBL] [Abstract][Full Text] [Related]
76. A family of autosomal dominant hypocalcemia with an activating mutation of calcium-sensing receptor gene. Chikatsu N; Watanabe S; Takeuchi Y; Muraosa Y; Sasaki S; Oka Y; Fukumoto S; Fujita T Endocr J; 2003 Feb; 50(1):91-6. PubMed ID: 12733714 [TBL] [Abstract][Full Text] [Related]